Hints and tips:
Showing results for Teva Pharmaceutical Industires, Ltd
...The leader of the pack was Teva Pharmaceuticals, whose market capitalisation reached $60bn in 2015. Teva now sits in the crosshairs of law enforcement....
...A $5bn “sustainability-linked” bond sold by Teva Pharmaceutical Industries on Tuesday was the largest of its kind, but drew immediate questions from some investors about its environmental and social claims...
...Teva declined to comment. Lumen and UltraTech did not respond to a request for comment. *This story has been amended to indicate that Teva is an Israel-based drugmaker....
...“Pharmaceutical companies need to take seriously the prospect that the [commission] may instigate an inquiry into such practices.”...
...Teva is one of four pharmaceutical companies in the midst of an opioid trial in California and is accused of engaging in misleading marketing which played down the risks of opioid addiction....
...The European Commission has fined pharmaceutical group Teva and its subsidiary and former rival Cephalon a combined €60.5m for conspiring to fix the price of sleep disorder drug modafinil....
...Pharmaceutical group Teva has been charged in the US with conspiring to fix the price of generic drugs, including a common cholesterol treatment, after it refused to settle with the US Department of Justice...
...On Tuesday, Israel’s Teva became the seventh drugmaker to be charged in the US with conspiring to fix the price of generic drugs....
...As the coronavirus outbreak affects production of drugs and active pharmaceutical ingredients in China, Mr Schultz said Teva is working to ensure it has substitutions for raw materials....
...To boost supplies of antimalarials, generics manufacturers Teva and Novartis’ Sandoz have pledged to donate millions of doses to US hospitals....
...The pharmaceutical company now expects net revenues of between $17.2bn and $17.4bn in 2019 and non-GAAP earnings per share of between $2.30 and $2.50....
...Shares in Teva jumped 9 per cent in late afternoon trading in New York, while Johnson & Johnson stock was flat....
...Teva’s better than expected earnings failed to allay investor concerns about potential legal liabilities and the departure of the chief financial officer, sending shares in the Israeli pharmaceutical company...
...Teva Pharmaceuticals, the only remaining manufacturer, fell 1.6 per cent to $7.38, after losing 3.5 per cent during the trading day....
...Teva Pharmaceuticals will pay $85m to Oklahoma to settle claims that it played a part in fuelling the state’s opioid crisis....
...Revenues in the US, Teva’s largest market, fell 20 per cent to $1.9bn. Teva lost $105m in the quarter, compared with net income of $1bn in the same quarter the year before....
...Teva Pharmaceutical has warned that 2019 will be a “trough” for the company as the world’s largest generic drugmaker forecast lower earnings and revenue because of generic competition to its branded multiple...
...Teva got a shot in the arm on Thursday from the long-awaited approval by US regulators of its generic version of Mylan’s EpiPen allergy injector....
...But there is a simpler reason why octogenarian Warren Buffett was unsure in a Monday television interview about why his Berkshire Hathaway had recently bought a $377m stake in Teva Pharmaceutical, the troubled...
...Israeli drugmaker Teva Pharmaceutical’s US shares shot up in after-hours trade on Wednesday after Berkshire Hathaway said it had taken a new stake in the company, signalling confidence by famed investor...
...Friday’s downgrade leaves Teva’s rating at Ba2, from Baa3....
...Shares in Israel’s Teva Pharmaceutical, the world’s largest generic drugmaker, fell sharply after it forecast a drop in revenue in 2018 in spite of aggressive cost-cutting that will lose as many as 14,000...
...Teva factories across the country would strike the entire day. A representative for the Israeli-based pharmaceutical company declined to comment on the reports....
...Teva Pharmaceutical’s US-listed shares received a shot in the arm on Friday following a report that the struggling Israeli drugmaker could be looking to cut up to 10,000 jobs in a bid to reduce costs and...
...It comes after the drugmaker took a write down of nearly $2bn on its Teva holding in the first quarter....
International Edition